North America Synthetic Opioids Market, By Product Type (Synthetic Opioids (Methadone, Fentanyl, Meperidine), Semi Synthetic Opioids (Hydrocodone, Oxymorphone, Oxycodone, Hydromorphone, Buprenorphine)), By Application (Pain Management, De-Addiction), By D

North America Synthetic Opioids Market, By Product Type (Synthetic Opioids (Methadone, Fentanyl, Meperidine), Semi Synthetic Opioids (Hydrocodone, Oxymorphone, Oxycodone, Hydromorphone, Buprenorphine)), By Application (Pain Management, De-Addiction), By Distribution Channel (Retail Outlets, Hospitals), and By Region (U.S., Canada) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Synthetic Opioids (CVIS) are opioid receptor agonists and act primarily on the brain and spinal cord and are used for pain relief. Most commonly prescribed synthetic opioids include, methadone, fentanyl and meperidine. Increasing prevalence of cancer is expected to boost growth of North America synthetic opioids market over the forecast period. Increasing adoption of expansion strategies from major market players through strategic investments, licensing agreements, and acquisitions for strengthening their market positioning is also anticipated to assist the growth of the market.

Key features of the study:

This report provides in-depth analysis of the Synthetic Opioids market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the North America Synthetic Opioids market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Purdue Pharma LP, Pfizer Inc., Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals, Endo International plc, West-Ward Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Mylan N.V., Impax Laboratories, Inc., and Indivior Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The North America Synthetic Opioids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America Synthetic Opioids market

Detailed Segmentation:

Synthetic Opioids Market, By Product Type :
Synthetic Opioids
Methadone
Fentanyl
Meperidine
Semi Synthetic Opioids
Hydrocodone
Oxymorphone
Oxycodone
Hydromorphone
Buprenorphine
Synthetic Opioids Market, By Application:
Pain Management
De-Addiction
Synthetic Opioids Market, By Distribution Channel:
Retail Outlets
Hospitals
Synthetic Opioids Market, By Region:
U.S.
By Product Type :
Synthetic Opioids
Methadone
Fentanyl
Meperidine
Semi Synthetic Opioids
Hydrocodone
Oxymorphone
Oxycodone
Hydromorphone
Buprenorphine
By Application
Pain Management
De-Addiction
By Distribution Channel
Retail Outlets
Hospitals
Canada
By Product Type :
Synthetic Opioids
Methadone
Fentanyl
Meperidine
Semi Synthetic Opioids
Hydrocodone
Oxymorphone
Oxycodone
Hydromorphone
Buprenorphine
By Application
Pain Management
De-Addiction
By Distribution Channel
Retail Outlets
Hospitals
Company Profiles
Purdue Pharma LP *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Pfizer Inc.
Janssen Pharmaceuticals, Inc.
Teva Pharmaceuticals
Endo International plc.
West-Ward Pharmaceuticals
Mallinckrodt Pharmaceuticals plc.
Mylan N.V.
Impax Laboratories, Inc.
Indivior Plc.
“*” marked represents similar segmentation in other categories in the respective section.